CIK 0001727196 · Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823750435
- Phone
- 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,281 | 1,282 | ||
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,250 | 14,063 | ||
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,571 | 53,036 | ||
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,035 | 34,820 | ||
| 2025-10-08 | Hallal David Chief Executive Officer | Gift | −205,000 | 1,599,095 | ||
| 2025-10-07 | AKKARAJU SRINIVAS Director | Purchase | +12,796 | $39.31 | $503K | 513,235 |
| 2025-10-07 | AKKARAJU SRINIVAS Director | Purchase | +12,400 | $40.18 | $498K | 525,635 |
| 2025-10-07 | AKKARAJU SRINIVAS Director | Purchase | +4,403 | $40.97 | $180K | 530,038 |
| 2025-10-06 | AKKARAJU SRINIVAS Director | Purchase | +18,414 | $37.89 | $698K | 405,828 |
| 2025-10-06 | AKKARAJU SRINIVAS Director | Purchase | +80,863 | $38.68 | $3.1M | 486,691 |
| 2025-10-06 | AKKARAJU SRINIVAS Director | Purchase | +13,748 | $39.52 | $543K | 500,439 |
| 2025-10-03 | AKKARAJU SRINIVAS Director | Purchase | +11,011 | $35.61 | $392K | 11,011 |
| 2025-10-03 | AKKARAJU SRINIVAS Director | Purchase | +56,703 | $36.74 | $2.1M | 67,714 |
| 2025-10-03 | AKKARAJU SRINIVAS Director | Purchase | +319,700 | $37.42 | $12.0M | 387,414 |
| 2025-09-22 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | −3,353 | $30.67 | $103K | 108,964 |
| 2025-09-16 | Peng Katie Director | Sale 10b5-1 | −930 | $32.48 | $30K | 33,990 |
| 2025-09-16 | Peng Katie Director | Sale 10b5-1 | −76 | $33.20 | $3K | 33,914 |
| 2025-09-16 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | −3,178 | $33.52 | $107K | 112,317 |
| 2025-08-18 | Parlavecchio Caryn CHRO | Sale | −2,178 | $31.17 | $68K | 155,464 |
| 2025-07-16 | FLIER JEFFREY S. Director | Sale 10b5-1 | −11,136 | $40.02 | $446K | 0 |
Page 6 of 12 · 227 trades